9 - 14 Nov 2020
ON DEMAND CONTENT
To view plenary, scientific and abstract sessions please click on 'Sessions' and then 'On demand'
To view industry sessions please visit the exhibition and the sessions can be found on the exhibitors profile. Additional information on industry content is provided on this page below.
WELCOME TO BSH 2020 VIRTUAL
Thank you for registering for BSH 2020 Virtual. As a registered delegate, you have exclusive access to presentations from experts on current clinical practice and the latest developments in haematology. You will also be able to access research from colleagues via the abstracts and poster presentations, and you will have the opportunity to engage with industry partners via the virtual exhibition space. All content from the live programme was recorded, so you can view sessions on demand until November 2021.
To access the recordings from the sessions scheduled within the porgramme click here.
You can select which sponsors you want to view and take a look at their offerings. If you want to find out more from a particular exhibitor, you can choose to message them, arrange a meeting or contact them separately. We are also pleased to host profiles for some of our key BSH partners, including the European Haematology Association (EHA) and the American Society of Hematology (ASH). The exhibition will be open for 12 months, so you can access all content until November 2021.
We hope you will enjoy the virtual experience. If you have any queries, please contact the team via email.
HIGHLIGHTS
INDUSTRY SYMPOSIA
We would like to thank our industry partners for supporting BSH and providing further content for the BSH 2020 Virtual programme. Our Industry Symposia have moved to a new location on the event platform, take the opportunity to hear from our industry partners, and watch their recorded Symposia via their exhibition stands.
For further details on any of the topics discussed during the symposia, please do reach out to the relevant sponsor.
AstraZeneca: Chronic Lymphocytic Leukaemia (CLL)
EUSA Pharma: Castleman disease: Ongoing challenges and the pursuit of optimal patient care
Kite, A Gilead Company: CAR T in the UK: Achieving more together for our patients
Sanofi Genzyme: Reframing possibilities in relapsed and refractory multiple myeloma
Jazz Pharmaceuticals: Strategies for maximising survival: Advances in high-risk* AML
Grifols: Practical Experience with a New Treamtment for Chronic ITP
Abbvie: Covering all lines in CLL: Venclyxto (venetoclax) to trigger deep response
Novartis: MPN Patient Management: A Real World Perspective
Novartis: The Current Treatment Paradigm for Treatment of Acute Myeloid Leukaemia
BSH 60th Anniversary
The first meeting of BSH took place in London on 19 November 1960. For 60 years, BSH has been dedicated to helping members support people with blood disorders and diseases. We are planning to use our 60th anniversary as an opportunity to recognise the tremendous contribution haematology professionals have made to advancing the specialty and transforming patient care.
Enjoy an exclusive preview of the following anniversary content:
· • BSH 60th Anniversary Address - Professor Adele Fielding, BSH President
· • An interview with Professor Victor Hoffbrand (BSH President from 1989-90), led by Suthesh Sivapalaratnam
Our full anniversary activities have been launched and are available on the BSH website.
Speakers:
Professor Adele Fielding, BSH President
Speakers:
Professor Victor Hoffbrand
Suthesh Sivapalaratnam
GET IN CONTACT
bsh2020@mci-group.com
bsh2020speakers@mci-group.com
bsh2020industry@mci-group.com
bsh.reghot@mci-group.com
